These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 28645654

  • 1. Epigenome dysregulation in cholangiocarcinoma.
    O'Rourke CJ, Munoz-Garrido P, Aguayo EL, Andersen JB.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1423-1434. PubMed ID: 28645654
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Epigenetic regulation in the carcinogenesis of cholangiocarcinoma.
    Chiang NJ, Shan YS, Hung WC, Chen LT.
    Int J Biochem Cell Biol; 2015 Oct; 67():110-4. PubMed ID: 26100596
    [Abstract] [Full Text] [Related]

  • 4. Role of epigenetic alterations in cholangiocarcinoma.
    Tischoff I, Wittekind C, Tannapfel A.
    J Hepatobiliary Pancreat Surg; 2006 Oct; 13(4):274-9. PubMed ID: 16858537
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Involvement of Epigenomic Factors in Bile Duct Cancer.
    Rogalska-Taranta M, Andersen JB.
    Semin Liver Dis; 2022 May; 42(2):202-211. PubMed ID: 35738258
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic alterations associated with cholangiocarcinoma (review).
    Isomoto H.
    Oncol Rep; 2009 Aug; 22(2):227-32. PubMed ID: 19578760
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
    Yang W, Wang X, Zheng W, Li K, Liu H, Sun Y.
    Int J Oncol; 2013 Feb; 42(2):690-8. PubMed ID: 23254774
    [Abstract] [Full Text] [Related]

  • 13. Epigenetic mechanisms in gastric cancer.
    Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA.
    Epigenomics; 2012 Jun; 4(3):279-94. PubMed ID: 22690664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer.
    Amirkhah R, Naderi-Meshkin H, Shah JS, Dunne PD, Schmitz U.
    Cells; 2019 Aug 19; 8(8):. PubMed ID: 31430887
    [Abstract] [Full Text] [Related]

  • 16. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, Henrique R, Nelson WG, Shariat SF.
    Eur Urol; 2011 Oct 19; 60(4):753-66. PubMed ID: 21719191
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
    Wehbe H, Henson R, Meng F, Mize-Berge J, Patel T.
    Cancer Res; 2006 Nov 01; 66(21):10517-24. PubMed ID: 17079474
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y, Su M, Ou W, Wang H, Tian B, Ma J, Tang J, Wu J, Wu Z, Wang W, Zhou Y.
    Biomed Pharmacother; 2019 Sep 01; 117():109192. PubMed ID: 31387188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.